Second-line amrubicin vs topotecan in extensive-disease small cell lung cancer (ED-SCLC) sensitive to first-line platinum-based chemotherapy: updated results of a randomized phase 2 trial

被引：0
|
作者：
Jotte, R. [1 ]
Conkling, P. R. [2 ]
Reynolds, C. [3 ]
Shah, C. [4 ]
Galsky, M. [5 ]
Klein, L.
Fitzgibbons, J. F. [6 ]
McNally, R. [7 ]
Oliver, J. W. [8 ]
Renschler, M. [8 ]
机构：
[1] Rocky Mt Canc Ctr US Oncol, Denver, CO USA
[2] Virginia Oncol Associates US Oncol, Norfolk, VA USA
[3] Ocala Oncol Ctr US Oncol, Ocala, FL USA
[4] SUNY Upstate Med Univ, Syracuse, NY USA
[5] Nevada US Oncol, Ctr Comprehens Canc, Las Vegas, NV USA
[6] Sacred Heart Med Ctr US Oncol, Spokane, WA USA
[7] Celgene Corp, Biostat, Summit, NJ USA
[8] Celgene Corp, Clin Dev, Summit, NJ USA
来源：
EJC SUPPLEMENTS | 2009年 / 7卷 / 02期
关键词：
D O I：
10.1016/S1359-6349(09)71833-6
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：540 / 541
页数：2
相关论文
共 50 条
  • [31] THE EFFECT OF PROPHYLACTIC CRANIAL IRRADIATION (PCI) IN THE PATIENTS WITH EXTENSIVE-DISEASE SMALL-CELL LUNG CANCER (ED-SCLC): RESULTS OF A JAPANESE RANDOMIZED PHASE III TRIAL
    Naito, T.
    Takahashi, T.
    Yamanaka, T.
    Harada, H.
    Seto, T.
    Satouchi, M.
    Oizumi, S.
    Katakami, N.
    Shibata, K.
    Maemondo, M.
    Kiura, K.
    Okamoto, H.
    Minato, K.
    Yamamoto, N.
    ANNALS OF ONCOLOGY, 2014, 25
  • [32] RESULTS OF A RANDOMIZED PHASE III STUDY OF SINGLE-AGENT AMRUBICIN (AMR) VERSUS CARBOPLATIN AND ETOPOSIDE (CE) IN ELDERLY PATIENTS WITH EXTENSIVE-DISEASE SMALL CELL LUNG CANCER (ED-SCLC)
    Hida, N.
    Okamoto, H.
    Horai, T.
    Nakagawa, K.
    Nishiwaki, Y.
    Yokoyama, A.
    Katakami, N.
    Shibuya, M.
    Saijo, N.
    Fukuoka, M.
    ANNALS OF ONCOLOGY, 2010, 21 : 148 - 148
  • [33] HEALTH STATE IN FIRST (1L) AND SECOND LINE (2L) EXTENSIVE-DISEASE SMALL CELL LUNG CANCER (ED-SCLC) TREATED IN US COMMUNITY ONCOLOGY CENTERS
    Schwartzberg, L. S.
    Hussein, M.
    Monte, M.
    Korytowsky, B.
    Singh, P.
    Gillis, L. B.
    Yang, J.
    Bobiak, S.
    VALUE IN HEALTH, 2016, 19 (03) : A159 - A160
  • [34] Topotecan and etoposide as first-line therapy for extensive disease small cell lung cancer: a phase II trial of a platinum-free regimen
    Reck, M
    Groth, G
    Buchholz, E
    Goetz, E
    Gatzemeier, U
    Manegold, C
    LUNG CANCER, 2005, 48 (03) : 409 - 413
  • [35] Real-world analysis of outcomes of first-line chemo-immunotherapy in patients with extensive disease small cell lung cancer (ED-SCLC)
    Zellweger, N. M.
    Schmid, S.
    Bertschinger, M.
    Waibel, C.
    Cerciello, F. W. F.
    Froesch, P. R.
    Mark, M. T.
    Bettini, A.
    Hauptle, P.
    Blum, V.
    Litke, T.
    Helfenstein, F.
    Frueh, M.
    Mauti, L. A.
    Rothschild, S. I.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1251 - S1251
  • [36] Cabazitaxel Versus Topotecan in Patients with Small-Cell Lung Cancer with Progressive Disease During or After First-Line Platinum-Based Chemotherapy
    Evans, Tracey L.
    Cho, Byoung Chul
    Udud, Katalin
    Fischer, Juergen R.
    Shepherd, Frances A.
    Martinez, Pablo
    Ramlau, Rodryg
    Syrigos, Konstantinos N.
    Shen, Liji
    Chadjaa, Mustapha
    Wolf, Martin
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (08) : 1221 - 1228
  • [37] TORIPALIMAB COMBINED WITH PLATINUM-BASED CHEMOTHERAPY AS A SECOND-LINE TREATMENT FOR SMALL CELL LUNG CANCER (SCLC) WITH BRAIN METASTASES: A CASE REPORT
    Fan, Jieqiong
    Zhang, Yao
    Mo, Xiaofei
    Guo, Jing
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A662 - A662
  • [38] Second-line treatment outcomes in Extensive Stage Small Cell Lung Cancer (ES-SCLC) patients after first-line immuno-chemotherapy
    Wan, Rui
    Fan, Linjie
    Zhong, Jia
    Duan, Jianchun
    Wang, Zhijie
    Hao, Xuezhi
    Wang, Jie
    CANCER RESEARCH, 2023, 84 (06)
  • [39] A Study of Sintilimab Combined with Anlotinib and chemotherapy as Second-Line or Later Therapy in Extensive-Disease Small Cell Lung Cancer
    Wang, Z.
    Han, X.
    Guo, J.
    Li, L.
    Huang, Y.
    Ma, L.
    Zhao, M.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S710 - S710
  • [40] Survival by Response to First-line Platinum-Based Therapy Among Patients With Extensive Disease Small Cell Lung Cancer
    Danese, M.
    Gleeson, M.
    Lubeck, D.
    Penrod, J.
    Korytowsky, B.
    Yuan, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2043 - S2043
12345